SREBF1 and metabolic syndrome: Consistently, a previous study demonstrated that ursolic acid decreased SREBP-1c, FASN, and ACC1 expression levels via activating PPARα in the liver, alleviating liver lipid accumulation and dyslipidemia in obese rats [35].